SC 13GNRIXCIK 0001549595

Nurix Therapeutics, Inc.

Name: SEC EDGAR filing 0001193125-26-399480
Creator: Nurix Therapeutics, Inc.
License: https://www.usa.gov/government-works

5%+ passive stake (SC 13G) filed September 23, 2026.

Short-form disclosure of beneficial ownership above 5% by passive investors with no control intent.

Open the filing on SEC.gov

New to the SC 13G? What it is and how to read one

Filing facts

Accession number: 0001193125-26-399480
Filer: Nurix Therapeutics, Inc.
Ticker: NRIX
CIK: 0001549595
Form type: SC 13G
Form description: 5%+ passive stake
Filed at: September 23, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: September 24, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1549595/000119312526399480/0001193125-26-399480-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Nurix Therapeutics, Inc. (0001549595) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001193125-26-399480.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.